Abstract
Plants have several advantages over the system for strategic production of useful biomolecules and proteins. Plant molecular farming is the genetic manipulations of the plants for production of desirable proteins and other useful biomolecules through various biotechnological approaches. Moreover, plants have been recognized as potential and natural sources of pharmaceutical products including various types of biomolecules including vaccines, proteins, antibodies, therapeutic entities, and essential blood substitutes. In addition, mammalian-derived recombinant DNA drugs, plant-derived antibodies, edible vaccines, and useful proteins are advantageous and are free of mammalian viral vector as well as other pathogens related to human. Plant-made biopharmaceuticals are safer, cheaper, can be commercially produced, and easily stored. In this article, we have described several plant diverse systems for the commercial production of useful proteins, enzymes, antibodies, and vaccines with desirable traits. Several advantages as well as disadvantages of the particular system of the plant molecular farming are also discussed. We have also described the product of plant molecular farming currently available in the market on commercial basis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
A Hiatt , R Cafferkey, K Bowdish (1989). Production of antibodies in transgenic plants. Nature. (2): 342 (6245): 76–8.
Andrea Barta, Karin Sommergruber, Diana Thompson, Klaus Hartmuth, Marjori A. Matzke & Antionius J. M. Matzke (1986). The expression of a nopaline synthase — human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Molecular Biology. (6): 347–357.
C O Tacket , H S Mason, G Losonsky, J D Clements, M Levine, C J Arntzen (1998a). Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med. (5):607–9.
Chong, D.K.X. and Langridge, W.H.R. (2000) Expression of full-length bioactive antimicrobial human lactoferrin in potato plants. Transgenic Res. 9, 71–78
Commandeur, U. et al. (2003) The biosafety of molecular farming in plants. AgBiotechNet 5, 110.
De Wilde, C. et al. (2002) Expression of antibodies and Fab fragments in transgenic potato plants: a case study for bulk production in crop plants. Mol. Breed. 9, 2871–2882.
Drake P.M., Barbi T., Sexton A., Mcgowan E., Stadlmann J., Navarre C., Ma J.K.C. (2009). Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco. The FASEB Journal. (23): 3581–3589.
Elizabeth E. Hood, Derrick R. Witcher, Sheila Maddock, Terry Meyer, Chris Baszczynski, Michele Bailey, Pam Flynn, James Register, Lisa Marshall, Diane Bond, Ellen Kulisek, Ann Kusnadi, Roque Evangelista, Zivko Nikolov, Cynthia Wooge, Richard J. Mehigh, Ronald Hernan, William K. Kappel, David Ritland, Chun Ping Li & John A. Howard (1997). Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Molecular Breeding. (3): 291–306.
Fraley RT, Rogers SG, Horsch RB, Sanders PR, Flick JS, Adams SP, Bittner ML, Brand LA, Fink CL, Fry JS, Galluppi GR, Goldberg SB, Hoffman NL, Woo SC (1983). Expression of bacterial genes in plant cells. Proc Natl Acad Sci USA (80):4803–4807.
Franken E, Teuschel U and Hain (1997). R Recombinant proteins from transgenic plants. Curr Opin Biotech. (8): 411–416.
Giddings, G. (2001) Transgenic plants as protein factories. Curr. Opin. Biotechnol. 12, 450–454.
Henry Daniell,Choun-Sea Lin, Ming Yu, and Wan-Jung Chang (2016). Chloroplast genomes: diversity, evolution and applications in genetic engineering. Genome Biol. (17):34.
Hood, E.E. (2002) From green plants to industrial enzymes. Enzyme & Microbial Technol 30, 279–283.
Horn ME, Woodard SL and Howard JA (2004). Plant molecular farming: systems and products. Plant Cell Rep. (22): 711–720.
Houdebine L.M., Attal J. (1999). Internal ribosome entry sites (IRESs): reality and use. Transgenic Research. (8): 157–177.
J Pen , L Molendijk, W J Quax, P C Sijmons, A J van Ooyen, P J van den Elzen, K Rietveld, A Hoekema (1992). Production of active Bacillus licheniformis alpha-amylase in tobacco and its application in starch liquefaction. Biotechnology (N Y). 10 (3):292–6.
Jeffrey M. Staub, Bradley Garcia, Julie Graves, Peter T. J. Hajdukiewicz, Priscilla Hunter, Narender Nehra, Vikram Paradkar, Michael Schlittler, James A. Carroll, Lori Spatola, Dannette Ward, Guangning Ye, and Douglas A. Russell (2000). High-yield production of a human therapeutic protein in tobacco chloroplasts. Nature America Inc. (18): 333–338.
Kamenarova, K., Abumhadi, N., Gecheff, K. and Atanassov, A (2005). Molecular farming in plants: an approach of agricultural biotechnology. Journal of cell and molecular biology. (4):77–86.
Lamphear BJ, Jilka JM, Kesl L, Welter M, Howard JA, Streatfield SJ (2004). A corn-based delivery system for animal vaccines: an oral transmissable gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine.
Ma J.K.C A Hiatt, M Hein, N D Vine, F Wang, P Stabila, C van Dolleweerd, K Mostov, T Lehner (1995). Generation and assembly of secretory antibodies in plants. Science. (5): 268(5211):716–9.
Ma J.K.C., Drake P.M.W., Chargelegue D., Obregon P., Prada A. (2005). Antibody processing and engineering in plants, and new strategies for vaccine production. Vaccine. (23): 1814–1818.
Maas, J. L., Galletta, G. J., & Stoner, G. D. (1991). Ellagic acid, an anticarcinogen in fruits, especially in strawberries: a review. HortScience. 26(1), 10–14.
Mason H.S., Lam D.M., Arntzen C.J. (1992). Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci U S A. 89(24):11745–9.
Mason, H.S. et al. (2002) Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med. 8, 324–329.
Peter C. Sijmons, Ben M. M. Dekker, Barbara Schrammeijer, Theo C. Verwoerd, Peter J. M. van den Elzen & Andre Hoekema (1990). Production of Correctly Processed Human Serum Albumin in Transgenic Plants. Bio/Technology. (8): 217–221.
Richter, L.J. et al. (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18, 1167–1171.
Ruggiero F, Exposito J-Y, Bournat P, Gruber V, Perret S, Comte J, Olagnier B, Garrone R, Thiesen M, (2000). Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett. (469):132–136.
Sala, F. et al. (2003) Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine 21, 803–808.
Schillberg S, Fischer R and Emans N. (2003). Molecular farming of antibodies in plants. Naturwissenschften. (90): 145–155.
Schillberg S, Raven N, Fischer R, Twyman RM, Schiermeyer A (2013). Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures. Curr Pharm Des, (31):5531–42.
Schillberg, S. et al. (2002) Antibody molecular farming in plants and plant cells. Phytochem. Rev. 1, 45–54.
Schunmann, P.H.D. et al. (2002) Biopharming the SimpliREDe HIV diagnostic reagent in barley, potato and tobacco. Mol. Breed. 9, 113–121.
Stephen P. Mayfield, Scott E. Franklin, and Richard A. Lerner (2003). Expression and assembly of a fully active antibody in algae. PNAS. (2) 438–442.
Stoger, E. et al. (2002a) Plantibodies: applications, advantages and bottlenecks. Curr. Opin. Biotechnol. 13, 161–166.
Stoger, E. et al. (2002b) Practical considerations for pharmaceutical antibody production in different crop systems. Mol. Breed. 9, 149–158.
Susan L Woodard , Jocelyne M Mayor, Michele R Bailey, Donna K Barker, Robert T Love, Jeffrey R Lane, Donna E Delaney, Janet M McComas-Wagner, Hanuman D Mallubhotla, Elizabeth E Hood, Lawrence J Dangott, Shane E Tichy, John A Howard. (2003a). Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol Appl Biochem. (38): 123–30.
Tacket, C.O. et al. (1998b) Immunogenicity in humans of a recombinant bacterial-antigen delivered in transgenic potato. Nat.Med. 4, 607–609.
Tacket, C.O. et al. (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182, 302–305.
Twyman RM, Schillberg S, Fischer R (2012). The Production of Vaccines and Therapeutic Antibodies in Plants, Molecular Farming in Plants: Recent Advances and Future Prospects. 145–159.
Valkova R, Apostolova E, Naimov S (2013). Plant molecular farming: opportunities and challenges, Journal of the Serbian Chemical Society. (78): 407415.
Woodard SL, Mayor JM, Bailey MR, Barker DK, Love RT, Lane JR, Delaney DE, McComas-Wagner JM, Mallubhotla HD, Hood EE, Dangott LJ, Tichy SE, Howard JA (2003b). Maizederived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol Appl Biochem (38):123–130.
Xiaorong Zhang, Dan W. Urry & Henry Daniell (1996). Expression of an environmentally friendly synthetic protein-based polymer gene in transgenic tobacco plants. Plant Cell Reports (16): 174–179.
Yu, J. and Langridge, W. (2003) Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Res. 12, 163–169.
Zhong G-Y, Peterson D, Delaney DE, Bailey M, Witcher DR, Register JC III, Bond D, Li C-P, Marshall L, Kulisek E, Ritland D, Meyer T, Hood EE, Howard JA, (1999). Commercial production of aprotinin in transgenic maize seeds. Mol Breed. (5):345–356.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kumar, A., Singh, A., Singh, A. (2022). Plant Molecular Farming: A Marvelous Biotechnological Approach in Agricultural Production. In: Kumar, A., Kumar, P., Singh, S.S., Trisasongko, B.H., Rani, M. (eds) Agriculture, Livestock Production and Aquaculture. Springer, Cham. https://doi.org/10.1007/978-3-030-93262-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-93262-6_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-93261-9
Online ISBN: 978-3-030-93262-6
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)